Zai Capex To Operating Cash Flow from 2010 to 2024

ZLAB Stock  USD 28.09  1.66  6.28%   
Zai Lab's Capex To Operating Cash Flow is increasing over the years with very volatile fluctuation. Capex To Operating Cash Flow is expected to dwindle to -0.04. From 2010 to 2024 Zai Lab Capex To Operating Cash Flow quarterly data regression line had arithmetic mean of (0.08) and significance of  0.74. View All Fundamentals
 
Capex To Operating Cash Flow  
First Reported
2010-12-31
Previous Quarter
(0.04)
Current Value
(0.04)
Quarterly Volatility
0.05883585
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zai Lab financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zai Lab's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.7 M, Interest Expense of 17.6 M or Selling General Administrative of 295.7 M, as well as many indicators such as Price To Sales Ratio of 0.91, Dividend Yield of 0.0 or PTB Ratio of 0.34. Zai financial statements analysis is a perfect complement when working with Zai Lab Valuation or Volatility modules.
  
Check out the analysis of Zai Lab Correlation against competitors.
For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.

Latest Zai Lab's Capex To Operating Cash Flow Growth Pattern

Below is the plot of the Capex To Operating Cash Flow of Zai Lab over the last few years. It is Zai Lab's Capex To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zai Lab's overall financial position and show how it may be relating to other accounts over time.
Capex To Operating Cash Flow10 Years Trend
Very volatile
   Capex To Operating Cash Flow   
       Timeline  

Zai Capex To Operating Cash Flow Regression Statistics

Arithmetic Mean(0.08)
Coefficient Of Variation(76.04)
Mean Deviation0.03
Median(0.06)
Standard Deviation0.06
Sample Variance0
Range0.2472
R-Value0.09
Mean Square Error0
R-Squared0.01
Significance0.74
Slope0
Total Sum of Squares0.05

Zai Capex To Operating Cash Flow History

2024 -0.045
2023 -0.0428
2022 -0.068
2021 -0.0345
2020 -0.0494
2019 -0.0798
2018 -0.1

About Zai Lab Financial Statements

Zai Lab stakeholders use historical fundamental indicators, such as Zai Lab's Capex To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Although Zai Lab investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zai Lab's assets and liabilities are reflected in the revenues and expenses on Zai Lab's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zai Lab. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capex To Operating Cash Flow(0.04)(0.04)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zai Lab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zai Lab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zai Lab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zai Lab Stock:
Check out the analysis of Zai Lab Correlation against competitors.
For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. If investors know Zai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zai Lab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.80)
Revenue Per Share
3.647
Quarterly Revenue Growth
0.477
Return On Assets
(0.21)
Return On Equity
(0.35)
The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zai Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.